Medicine

99Tcm sestamibi — a new agent for parathyroid imaging

A. J. Coakley, A. Kettle, C. P. Wells, M. O'Doherty, Ruth E. Collins

1989.11.1NUCLEAR MEDICINE COMMUNICATIONS

DOI: 10.1097/00006231-198911000-00003

tlooto Summary

The higher uptake of sestamibi and better imaging properties of its 99Tcm radiolabel means that the agent may replace thallium for routine preoperative parathyroid localization.

Abstract

Abstract is not available.

Citation format

COAKLEY, A. J., et al. 99Tcm sestamibi — a new agent for parathyroid imaging. NUCLEAR MEDICINE COMMUNICATIONS, 1989, 10: 791–794.